These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

595 related items for PubMed ID: 16612244

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Application of three-dimensional body scanner: observation of prevalence of metabolic syndrome.
    Lin JD, Chiou WK, Weng HF, Fang JT, Liu TH.
    Clin Nutr; 2004 Dec; 23(6):1313-23. PubMed ID: 15556253
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K, Bayram F, Capak M, Tanriverdi F, Karaman A, Ozturk A, Altunbas H, Gökce C, Kalkan A, Yazici C.
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Metabolic risk factors and markers of cardiovascular and renal damage in overweight subjects.
    Bigazzi R, Bianchi S, Batini V, Guzzo D, Campese VM.
    Am J Hypertens; 2006 Apr; 19(4):426-31. PubMed ID: 16580581
    [Abstract] [Full Text] [Related]

  • 11. Prevalence, correlates, awareness, treatment, and control of hypertension in a middle-aged urban population in Kerala.
    Zachariah MG, Thankappan KR, Alex SC, Sarma PS, Vasan RS.
    Indian Heart J; 2003 Apr; 55(3):245-51. PubMed ID: 14560934
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2).
    Cheung BM, Wat NM, Man YB, Tam S, Cheng CH, Leung GM, Woo J, Janus ED, Lau CP, Lam TH, Lam KS.
    Am J Hypertens; 2008 Jan; 21(1):17-22. PubMed ID: 18091739
    [Abstract] [Full Text] [Related]

  • 14. The prevalence of impaired glucose metabolism in Hispanics with two or more risk factors for metabolic syndrome in the primary care setting.
    Neira CP, Hartig M, Cowan PA, Velasquez-Mieyer PA.
    J Am Acad Nurse Pract; 2009 Mar; 21(3):173-8. PubMed ID: 19302694
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the Global Cardiometabolic Risk Profile in Patients with hypertension disease survey.
    Kjeldsen SE, Naditch-Brule L, Perlini S, Zidek W, Farsang C.
    J Hypertens; 2008 Oct; 26(10):2064-70. PubMed ID: 18806632
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.